---
title: "Humacyte completes enrolment in Phase II/III trial of Human Acellular Vessel for vascular trauma repair"
date: "2023-07-31T11:22:35.000Z"
publishedDate: "31 juillet 2023"
summary: "Humacyte today announced completion of enrolment in its Phase II/III vascular trauma trial (V005) that is expected to support a Biologics License Application (BLA) filing for the company&#8217;s Human Acellular Vessel (HAV) in vascular trauma repair. A press release details that the HAV is designed to provide surgeons with an off-the-shelf bioengineered human artery that [&#8230;] The post Humacyte completes enrolment in Phase II/III trial of Human Acellular Vessel for vascular trauma repair appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/humacyte-completes-enrolment-in-phase-ii-iii-trial-of-human-acellular-vessel-for-vascular-trauma-repair/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-07-31-humacyte-completes-enrolment-in-phase-iiiii-trial-of-human-acellular-vessel-for-vascular-trauma-repair"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2023/07/Humacyte-HAV.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/humacyte-completes-enrolment-in-phase-ii-iii-trial-of-human-acellular-vessel-for-vascular-trauma-repair/"
---

![Humacyte completes enrolment in Phase II/III trial of Human Acellular Vessel for vascular trauma repair](https://interventionalnews.com/wp-content/uploads/sites/13/2023/07/Humacyte-HAV.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/humacyte-completes-enrolment-in-phase-ii-iii-trial-of-human-acellular-vessel-for-vascular-trauma-repair/*

## L’essentiel

Humacyte today announced completion of enrolment in its Phase II/III vascular trauma trial (V005) that is expected to support a Biologics License Application (BLA) filing for the company&#8217;s Human Acellular Vessel (HAV) in vascular trauma repair. A press release details that the HAV is designed to provide surgeons with an off-the-shelf bioengineered human artery that [&#8230;] The post Humacyte completes enrolment in Phase II/III trial of Human Acellular Vessel for vascular trauma repair appeared first on Interventional News .

## Lien source

https://interventionalnews.com/humacyte-completes-enrolment-in-phase-ii-iii-trial-of-human-acellular-vessel-for-vascular-trauma-repair/
